Related Product Information
Lipofectamine LTX® Reagent is a proprietary, animal-origin free formulation for the transfection of DNA into eukaryotic cells with low cytotoxicity. This reference provides a recommended procedure to transfect plasmid DNA into NTera2, human embryonal carcinoma stem cell line (ATCC No. CRL-1973) using Lipofectamine LTX® Reagent.
Important Guidelines for Transfection
Follow these important guidelines when transfecting NTera2 cells using Lipofectamine LTX® Reagent:
- Maintain cells at high density, keeping the same seeding conditions between experiments. Use low-passage cells; make sure cells are healthy and greater than 90% viable before transfection.
- Transfection can be performed both in the presence or absence of serum. Test serum-free media for compatibility with Lipofectamine LTX® Reagent.
- We recommend Opti-MEM® I Reduced Serum Medium (Cat. No. 31985-070) to dilute the DNA Lipofectamine LTX® Reagent before complexing.
- Using PLUS™ Reagent (Cat. No. 11514-015) enhances transfection performance in NTera2Cells
- Visit www.lifetechnologies.com/genedelivery or contact Technical Services for other specialized transfection protocols.
- Lipofectamine LTX® Reagent performs well with vector-based RNAi experiments. For siRNA and Stealth RNAi transfections, we recommend Lipofectamine RNAiMAX. Go to www.lifetechnologies.com/RNAi or contact Technical Service for more information.
Materials Needed
Have the following reagents on hand before beginning:
- NTera2 cells maintained in Dulbecco's Modified Eagle Medium (DMEM) (Cat. No. 10313-021) supplemented with 2 mM L-Glutamine (Cat. No. 25030-081), 10% fetal bovine serum (Cat No.16000-044). Grow cells at 37o C with 5% CO2.
- Lipofectamine LTX® Reagent (store at +4oC until ready to use)
- Opti-MEM® I Reduced Serum Media
- Appropriate tissue culture plates and supplies
31985070,11514015,25030081,10313021,16000044
Transfection of NTera2 Cells
Use this procedure to transfect plasmid DNA into NTera2cells in a 24-well format (for other formats, see Scaling Up or Down Transfections, below). All amounts and volumes are given on a per well basis.
- The day before transfection, remove media, wash once with PBS, and scrape cells with sterile cell scraper. Collect the cells. Plate 1.0x105 cells per well in 0.5 ml of complete growth medium. Cell density should be 80-90% confluent on the day of transfection.
- (Optional) The day of transfection, remove growth medium from cells and replace with 0.5 ml of complete growth medium.
- For each well of cells to be transfected, dilute 0.5 μg of DNA in 100 μl of Opti-MEM® I Reduced Serum Media without serum.
- If using PLUS™ Reagent: Mix PLUS™ Reagent gently before use, then add 0.5 μl PLUS™ Reagent (a 1:1 ratio to DNA) directly to the diluted DNA. Mix gently and incubate 5-15 minutes at room temperature.
- For each well of cells, add 1.75-3.25 μl of Lipofectamine LTX® Reagent into the above diluted Opti-MEM®:DNA solution, mix gently and incubate 30 minutes at room temperature to form DNA- Lipofectamine LTX® Reagent complexes.
- After 30 minute incubation, add 100 μl of the DNA- Lipofectamine LTX® Reagent complexes directly to each well containing cells and mix gently by rocking the plate back and forth.
- Complexes do not have to be removed following transfection. Incubate the cells at 37oC in a CO2 incubator for 18-24 hours post-transfection before assaying for transgene expression.
Scaling Up or Down Transfections
Culture vessel | Surface area per well | Volume plating medium | Cells per well | Volume dilution medium | DNA | Lipofectamine® LTX Reagent | PLUS™ Reagent |
---|
96-well | 0.3 cm2 | 100 μl | 2.5 x 104 | 20 μl | 100 ng | 0.35 - 0.65 μl | 0.1 μl |
48-well | 1 cm2 | 200 μl | 5 x 104 | 40 μl | 200 ng | 0.7 - 1.3 μl | 0.2 μl |
24-well | 2 cm2 | 500 μl | 1.25 x 105 | 100 μl | 500 ng | 1.75 - 3.25 μl | 0.5 μl |
12-well | 4 cm2 | 1 ml | 2.5 x 105 | 200 μl | 1 μg | 3.5 - 6.5 μl | 1.0 μl |
6-well | 10 cm2 | 2 ml | 6.25 x 105 | 500 μl | 2.5 μg | 8.75 - 16.25 μl | 2.5 μl |
25-0995W 17 Nov 2006
For Research Use Only. Not for use in diagnostic procedures.